Drug LitigationFDA’s Concerns about Zoloft Birth Defects

May 11, 2012

The federal government’s Food and Drug Administration (FDA) recently issued an updated warning that encouraged medical professionals to report adverse events related to Zoloft ingestion during pregnancy to the FDA’s MedWatch Program.

 

The reason for the FDA’s observation of Zoloft (sertraline) and similar SSRI antidepressants is understandable: in the last decade thousands of American women have reported giving birth to infants suffering from a host of prenatal birth defects, including persistent pulmonary hypertension (PPHN), and heart, brain, and physical birth defects. Many of these patients and their families are concerned that Zoloft may have played an important causal role in their child’s injury.

 

Do you have concerns about the relationship between your child’s birth defects and your Zoloft prescription? The attorneys and professionals at the Dallas-based law firm of Nachawati Law Group may be able to help you. Thanks to our experience and expertise, we know how to fight for victims just like you. For a free consultation, call us at 1.866.545.8364 or email [email protected] . We’re ready to fight for you!

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.

https://ntrial.com/ntrial/wp-content/uploads/Nachawati-Law-logo-White-2-160x25.png

©2025 Nachawati Law Group           Terms and Conditions | Privacy Policy